Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) Stock Overview
Explore Edwards Lifesciences Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
47.5B
P/E Ratio
44.50
EPS (TTM)
$1.81
ROE
0.10%
EW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Edwards Lifesciences Corporation (EW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 46.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $78.67.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 44.50 and a market capitalization of 47.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.